Table 1.
Representation of the matching criteria before and after matching, separated by female and male patients. For clinical parameters, frequencies (n and percentage) are displayed, and for morphological parameters, mean values are shown. Additionally, the table includes statistical results (p-values) comparing cohorts before and after matching. Post-matching, no differences were detectable, indicating successful cohort matching and establishing comparability.
| Whole Cohort (n = 283) | Matched Cohort (n = 180) | |||||
|---|---|---|---|---|---|---|
| Male (n = 95) | Female (n = 188) | Statistical Analysis | Male (n = 95) | Female (n = 195) | Statistical Analysis | |
| Age (mean) | 55.1 years | 55.6 years | p > 0.999 ** | 55.1 years | 53.6 years | p > 0.999 *** |
| Hypertension | 70 (24.7%) | 134 (47.4%) | p > 0.999 **** | 70 (73.7%) | 70 (73.7%) | p > 0.999 **** |
| Diabetes mellitus | 14 (5.0%) | 16 (5.7%) | p > 0.999 **** | 14 (14.7%) | 10 (10.5%) | p > 0.999 **** |
| Hyperlipidemia | 19 (6.7%) | 29 (10.3%) | p > 0.999 **** | 19 (20%) | 18 (19.0%) | p > 0.999 **** |
| Peripheral arterial disease | 4 (1.4%) | 3 (1.1%) | p > 0.999 **** | 4 (4.2%) | 1 (1.1%) | p > 0.999 **** |
| Heart disease | 15 (5.3%) | 25 (8.8%) | p > 0.999 ***** | 15 (15.8%) | 13 (13.7%) | p > 0.999 **** |
| Ischemic stroke | 9 (3.2%) | 11 (3.9%) | p > 0.999 **** | 9 (9.5%) | 1 (1.1%) | p > 0.999 **** |
| Obesity | 33 (11.7%) | 44 (15.6%) | p > 0.999 **** | 33 (34.7%) | 26 (27.4%) | p > 0.999 **** |
| Nicotine abuse | 62 (21.9%) | 85 (30.0%) | p = 0.031 **** | 62 (65.3%) | 68 (71.6%) | p > 0.999 **** |
| Alcohol abuse | 23 (8.1%) | 13 (4.6%) | p = 0.031 **** | 23 (24.2%) | 11 (11.6%) | p = 0.124 **** |
| Hmax (mean) | 5.9 | 5.6 | p > 0.999 * | 5.9 | 5.7 | p > 0.999 ** |
| Wmax (mean) | 5.7 | 5.7 | p > 0.999 * | 5.7 | 5.9 | p > 0.999 ** |
| Dmax (mean) | 7.6 | 7.3 | p > 0.999 * | 7.6 | 7.4 | p > 0.999 ** |
| Hortho (mean) | 5.0 | 4.9 | p > 0.999 * | 5.0 | 5.0 | p > 0.999 ** |
| Wortho (mean) | 6.6 | 6.4 | p > 0.999 * | 6.6 | 6.5 | p > 0.999 ** |
| Nmax (mean) | 4.7 | 4.7 | p > 0.999 * | 4.7 | 4.7 | p > 0.999 ** |
| Navg (mean) | 4.1 | 4.0 | p > 0.999 * | 4.1 | 4.0 | p > 0.999 ** |
| AR 1 (mean) | 1.1 | 1.1 | p > 0.999 * | 1.1 | 1.1 | p > 0.999 * |
| AR 2 (mean) | 1.2 | 1.3 | p > 0.999 * | 1.2 | 1.3 | p > 0.999 * |
| EI (mean) | 0.3 | 0.3 | p > 0.999 ** | 0.3 | 0.3 | p = 0.812 ** |
| NSI (mean) | 0.2 | 0.2 | p > 0.999 * | 0.2 | 0.2 | p > 0.999 *** |
| UI (mean) | 0.1 | 0.1 | p > 0.999 * | 0.1 | 0.1 | p = 0.36 ** |
| AA (mean) | 101.4 | 102.3 | p > 0.999 * | 101.4 | 99.3 | p > 0.999 ** |
| Ostium Area 1 (mean) | 15.7 | 15.9 | p > 0.999 * | 15.6 | 14.6 | p > 0.999 ** |
| Ostium Area 2 (mean) | 13.8 | 13.8 | p > 0.999 * | 13.8 | 13.1 | p > 0.999 ** |
| VA (mean) | 117.7 | 141.7 | p > 0.999 * | 117.7 | 115.8 | p > 0.999 ** |
| V_CH (mean) | 133.2 | 158.6 | p > 0.999 * | 133.2 | 130.5 | p > 0.999 ** |
| A_CH (mean) | 119.5 | 120.6 | p > 0.999 * | 119.5 | 117.4 | p > 0.999 ** |
| Alpha (mean) | 76.9 | 76.4 | p > 0.999 * | 76.9 | 78.7 | p > 0.999 * |
| Beta (mean) | 61.4 | 62.6 | p > 0.999 * | 61.4 | 59.3 | p > 0.999 * |
| Gamma (mean) | 41.8 | 40.9 | p > 0.999 * | 41.8 | 42.0 | p > 0.999 ** |
* t-test with Bonferroni–Holm correction; ** Mann–Whitney U test with Bonferroni–Holm correction; *** Welch test with Bonferroni–Holm correction; **** chi-square test with Bonferroni–Holm correction; ***** Fisher’s exact test with Bonferroni–Holm correction. Bald p-values represent significant results.